STZ OcuTox has unique experience in back of the eye assessment of drug effect and drug toxicity. Team members are regularly asked to give their advice on issues of ocular toxicity or assessment of pharmacodynamics or pharmacokinetics.

  • Selecting models for preclinical studies
  • Interpretation of ocular data
  • Drafting Ocular Toxicity Reports for regulatory authorities
  • Review and interpretation of preclinical studies
  • Assessment of existing preclinical packages
  • Preparation/review of preclinical sections of regulatory documents